CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

Masterclass Series

Real-World Evidence & Trials
Free Masterclass Live Series 2021

Join our masterclass series to learn about perspectives on real-world evidence studies from a trialist / statistician and epidemiologist / clinician, explained in clear non-technical terms and illustrated with examples from drugs and devices in multiple therapy areas.

OXON MasterClass Series

Speakers

Key Speaker

Stuart Pocock

Professor of Medical Statistics, London School of Hygiene & Tropical Medicine

Author of > 500 papers, including 70+NEJM/Lancets, mainly of clinical trials and epidemiology; extensive experience of EMA/FDA and Data Monitoring Committee  (including the Covid-19 adaptive platform DISCOVERY trial)

Chairman

Nawab Qizilbash

Senior Clinical Epidemiologist, OXON Epidemiology
Honorary Associate Professor in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine and Clinical Observer, Internal Medicine, Madrid Hospitals.
Formerly: Director, Clinical Epidemiology, GSK and Honorary Consultant Physician, Radcliffe Hospitals, Oxford

Who should attend

This Masterclass series is intended for a wide audience including: Epidemiology, HEOR, Safety, Statistics, Medical Affairs, Market Access, Marketing, Project Management and Outsourcing professionals in biopharmaceutical and device companies*.

You will learn about the role and pros and cons of Real-World Data studies compared with trials.

Guidance to overcome challenges in future Real-World Data studies will be discussed with Q&A sessions for technical and non-technical questions.

Take a look at the different sessions

Don’t miss out on your chance to learn from a leading expert and register for any or all masterclasses below.
Let us know if you cannot attend any live session and we can discuss alternative arrangements.

Convert to my timezone

TitleDateStart TimeDurationRegister
RWE Studies & Trials | Free Masterclass Series 2021: Live Session 4 - Individualizing Benefit-Risk SESSION 4: INDIVIDUALIZING BENEFIT-RISK
Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would benefit identification of patients for treatment and help eligibility for future trials and RWE studies.

TOPICS:
• A new method of individualising benefit-risk will be introduced and explained.
• Case studies will show its application from trials.
• Limitations will be outlined.
• Applicability to observational studies will be provided.
• How this method sits with current benefit-risk models used by regulators and reimbursement agencies.
• Benefits of this new method for Clinical Development, Value, Market Access, guidelines and patient management.

SPEAKERS:
Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine
Author of more than 500 papers, including 70+NEJM/Lancets, mainly of clinical trials and epidemiology; extensive experience of EMA/FDA and Data Monitoring Committee (including the Covid-19 adaptive platform DISCOVERY trial)

Nawab Qizilbash, Senior Clinical Epidemiologist, OXON Epidemiology
Honorary Associate Professor in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine and Clinical Observer, Internal Medicine, Madrid Hospitals.
Formerly: Director, Clinical Epidemiology, GSK and Honorary Consultant Physician, Radcliffe Hospitals, Oxford

DATE:
June 16, 2021 at 5pm CET | 4pm UK | 11am EDT | 8am PST

AGENDA:
Chair: Dr Nawab Qizilbash, Senior Clinical Epidemiologist, OXON and Honorary Associate Professor, London School of Hygiene & Tropical Medicine:
- Welcome and introductions (5 minutes)
Key Speaker: Stuart Pocock
- Programme: (45 minutes)
- Q&A session (10 minutes)

DETAILS:
- We will be using GoToWebinar.
- You can join our session by using a Mac, PC or a mobile device.
16 Jun, 202117:00 CEST1 hour
Register

SESSION 1

  • 17 MARCH 2021
LEARN MORE

SESSION 2

  • 21 APRIL 2021
LEARN MORE

SESSION 3

  • 19 MAY 2021
LEARN MORE

SESSION 4

  • 16 JUNE 2021
LEARN MORE

Contact us! It will only take a minute

CONTACT US